Found 11 matching trials
6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124) PHASE3 A multicenter, randomized, parallel-group, double-blind, fixed dose, 6-week...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688) PHASE3 The purpose of this trial is to assess the effect of asenapine 2.5 and 5 mg...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) PHASE3 The primary features of schizophrenia and schizoaffective disorder are char...
Show More Location
Multiple Locations
Learn More & Join Trial
A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Antipsychotics in Participants With Stable Schizophrenia PHASE2 The purpose of the study is to determine whether motivation/reward deficits...
Show More Location
Kings College London
Learn More & Join Trial
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107) PHASE3 Efficacy and safety of asenapine for the treatment of bipolar I disorder (m...
Show More Location
Multiple Locations
Learn More & Join Trial
Elpipodect (MK-8189) Multiple Dose Study in Healthy Volunteers and Schizophrenia Participants (MK-8189-003) PHASE1 This 3-part dose titration study will assess elpipodect safety, tolerabilit...
Show More Location
Multiple Locations
Learn More & Join Trial
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering PHASE3 The purpose of this research study is to find out the potential benefits an...
Show More Location
University of California Irvine Medical Center
Learn More & Join Trial
Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384) PHASE3 This study is being done to evaluate the efficacy and safety of asenapine a...
Show More Location
Forest Investigative Site 3017
Learn More & Join Trial
A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007) PHASE1 This 4-panel study will evaluate the safety, tolerability, pharmacokinetics...
Show More Location
California Clinical Trials ( Site 0001)
Learn More & Join Trial
To Determine Long Term Efficacy and Safety of Asenapine in Schizophrenic Patient Population (A7501012)(COMPLETED)(P05770) PHASE3 Schizophrenia is a brain disease. The condition may be associated with acut...
Show More Location
Multiple Locations
Learn More & Join Trial